People initiating therapy between 25 and 34 years of age gain as much as 1.8 years of life while spending up to 5.9 fewer years without diabetes
Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction
Dr Reddy's Laboratories is aiming to launch its version of semaglutide in Canada by May 2026 The expiry of semaglutide patent, the molecule in Novo Nordisk's weight-loss drugs Wegovy and Ozempic, in India is expected to shake up the country's drug industry, home to many generics majors
Also, showing a survival advantage with pembrolizumab encourages developers to evaluate broader use of immunotherapy in PROC
In phase 3 clinical trials, orforglipron at its highest studied dose (36 mg daily) produced an average weight loss of 11.2% (about 27 pounds) over 72 weeks
Suppositories should be stored in a cool, dry place, away from heat and direct sunlight